Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Esomeprazole Magnesium delayed release capsules.
The approved abbreviated new drug application (ANDA) is bio equivalent and therapeutically equivalent to the reference listed drug product Nexium delayed release capsules of AstraZeneca Pharmaceuticals. It is indicated in treatment of gastroesophageal reflux disease.